bibliographic resource 5786417 [br/5786417]
https://w3id.org/oc/corpus/br/5786417

is a
title
  • RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis.
publication date
  • 2016-01-01
contributor
format
identifier
part of